Stock PHARM PHARMING GROUP N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Pharming Group N.V.

Equities

PHARM

NL0010391025

Market Closed - Euronext Amsterdam
Other stock markets
 11:35:23 2024-05-03 am EDT 		5-day change 1st Jan Change
0.8985 EUR +0.06% Intraday chart for Pharming Group N.V. -0.17% -12.85%
Apr. 22 Pharming Group to Buy Back EUR123 Million of Bonds due 2025 MT
Apr. 18 Pharming Group to Issue EUR100 Million Convertible Bonds, Repurchase EUR125 Million Bonds MT

Evolution of the average Target Price on Pharming Group N.V.

Price target over the last 5 years

History of analyst recommendation changes

96f051bf9af59cb215.UZlIv2cPmzX9sdxpH2VSg7tjNoVcT-jMdw6G0klg0_Y.Fc571RNOqHKe55NaKzAI74wGfbcSLtmqWlr_vhgSgIYr7AGOBD_Ie9DIkQ~e58972680b3864ffb07a6ef495ceaab1

Analyst Recommendations on Pharming Group N.V.

RBC Raises Price Target on Pharming Group to EUR2.10 From EUR1.95, Keeps Outperform Rating MT
Oppenheimer Adjusts Pharming Group Price Target to $40 From $36, Maintains Outperform Rating MT
Oppenheimer Adjusts Pharming Group's Price Target to $36 From $43, Maintains Outperform Rating MT
Van Leeuwenhoeck issues research note on Pharming (PHAR.AS): Turning the Page PU
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.8985 EUR
Average target price
2 EUR
Spread / Average Target
+122.59%
High Price Target
2.1 EUR
Spread / Highest target
+133.72%
Low Price Target
1.85 EUR
Spread / Lowest Target
+105.90%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Pharming Group N.V.

RBC Capital Markets
Oppenheimer

Ratings for Pharming Group N.V.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PHARM Stock
  4. Consensus Pharming Group N.V.